PlainRecalls
FDA Drug Moderate Class II Terminated

Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.

Reported: December 16, 2020 Initiated: December 8, 2020 #D-0124-2021

Product Description

Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Shilpa Medicare Limited
Units Affected
2611 bottles
Distribution
Nationwide in the U.S.
Location
Polepally, Jadcherla, N/A

Frequently Asked Questions

What product was recalled?
Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.. Recalled by Shilpa Medicare Limited. Units affected: 2611 bottles.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on December 16, 2020. Severity: Moderate. Recall number: D-0124-2021.